DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Relationship Between Topiramate Use and Ocular Angle Status

Information source: Chinese University of Hong Kong
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Glaucoma, Angle-Closure

Intervention: Topiramate (Drug)

Phase: Phase 4

Status: Active, not recruiting

Sponsored by: Chinese University of Hong Kong

Official(s) and/or principal investigator(s):
Dexter YL Leung, MRCS, Principal Investigator, Affiliation: Hong Kong Eye Hospital
Howan Leung, MRCP, Principal Investigator, Affiliation: Chinese University of Hong Kong

Summary

We test the hypothesis whether topiramate narrows the angles which may render Asians more likely to suffer from acute angle closure glaucoma.

Clinical Details

Official title: Relationship Between Topiramate Use and Ocular Angle Status: A Prospective Pilot Study

Study design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study

Primary outcome:

Change(s) in ophthalmic parameters measured at baseline and after 4 weeks of treatment, including:

best-corrected visual acuity, refraction, Goldmann applanation tonometry, Gonioscopy, dilated fundus examination,

and ultrasound biomicroscopy of angle and anterior segment.

Detailed description: Topiramate is approved for the treatment of epilepsy and prophylaxis of migraine attacks. There were case reports of acute angle closure glaucoma (AACG) associated with its use. AACG is particularly common in Asians because of a higher prevalence of narrow angle., we test the hypothesis whether topiramate narrows the angles which may render them more likely to suffer from AACG.

Eligibility

Minimum age: 18 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Participants aged 18-75 with an indication for starting topiramate.

Exclusion Criteria:

- Patients with known allergy or intolerance to topiramate.

- Recent exposure to topiramate (<3 months).

- Moderate to severe renal failure.

- Known history of renal calculi or hepatic failure

- Inability to give informed consent.

- Pregnant women or women of child-bearing age who do not practise an acceptable means

of contraception.

- Patients known to have angle-closure glaucoma.

Locations and Contacts

Prince of Wales Hospital, Shatin, Hong Kong

Hong Kong Eye Hospital, Kowloon, Hong Kong

Additional Information

Starting date: September 2004
Ending date: July 2007
Last updated: October 30, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008